Skip to main content
Erschienen in: Molecular Neurodegeneration 1/2015

Open Access 01.12.2015 | Erratum

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility

verfasst von: Daniel Sevlever, Fanggeng Zou, Li Ma, Sebastian Carrasquillo, Michael G. Crump, Oliver J. Culley, Talisha A. Hunter, Gina D. Bisceglio, Linda Younkin, Mariet Allen, Minerva M. Carrasquillo, Sigrid B. Sando, Jan O. Aasly, Dennis W. Dickson, Neill R. Graff-Radford, Ronald C. Petersen, Ferenc Deák, Olivia Belbin, Kevin Morgan for ARUK consortium

Erschienen in: Molecular Neurodegeneration | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Daniel Sevlever and Fanggeng Zou contributed equally to this work.
The online version of the original article can be found under doi:10.​1186/​s13024-015-0015-x.
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​s13024-015-0015-x.

Authors’ contributions

DS was responsible for generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures, assisted in the data analysis and manuscript writing. FZ participated in the design of the study, was responsible for the TaqMan low-density array of VAMP1 transcripts, genotyping and assisted in the data analysis and manuscript writing. LM was responsible for the maintenance of the DNA samples, assisted in the genotyping and Aß ELISA. SC assisted in the generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures. MC performed the genotyping and dual luciferase assay for rs7390. OJC performed the dual luciferase assay for rs12964 and rs2072376. TAH supervised the genotyping of VAMP1. GB assisted in the maintenance of the DNA samples and genotyping. LY and MA performed the Aß ELISA. MMC participated in the design of the study, assisted in the genotyping and data analysis. SBS and JOA provided DNA samples for the study. DWD, NRG-R and RP provided DNA samples for the study as well as clinical and postmortem diagnoses. FD played a key role in the conception and design of the study. KM for the ARUK consortium provided DNA samples for the study, participated in the design of the study. OB participated in the design of the study, supervised the dual luciferase assay, and was responsible for the data analysis and writing of the manuscript. All authors critically revised the manuscript, gave final approval for submission and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Erratum

Following publication of this work [1], we noticed that we inadvertently failed to include Dr Ferenc Deák in the author list. The author list has now been corrected and the amended authors’ contributions section has been modified accordingly below.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Authors’ contributions

DS was responsible for generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures, assisted in the data analysis and manuscript writing. FZ participated in the design of the study, was responsible for the TaqMan low-density array of VAMP1 transcripts, genotyping and assisted in the data analysis and manuscript writing. LM was responsible for the maintenance of the DNA samples, assisted in the genotyping and Aß ELISA. SC assisted in the generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures. MC performed the genotyping and dual luciferase assay for rs7390. OJC performed the dual luciferase assay for rs12964 and rs2072376. TAH supervised the genotyping of VAMP1. GB assisted in the maintenance of the DNA samples and genotyping. LY and MA performed the Aß ELISA. MMC participated in the design of the study, assisted in the genotyping and data analysis. SBS and JOA provided DNA samples for the study. DWD, NRG-R and RP provided DNA samples for the study as well as clinical and postmortem diagnoses. FD played a key role in the conception and design of the study. KM for the ARUK consortium provided DNA samples for the study, participated in the design of the study. OB participated in the design of the study, supervised the dual luciferase assay, and was responsible for the data analysis and writing of the manuscript. All authors critically revised the manuscript, gave final approval for submission and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Daniel S, Fanggeng Z, Li M, Sebastian C, Crump MG, Culley OJ, et al. Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility. Mol Neurodegener. 2015;10:18.CrossRef Daniel S, Fanggeng Z, Li M, Sebastian C, Crump MG, Culley OJ, et al. Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility. Mol Neurodegener. 2015;10:18.CrossRef
Metadaten
Titel
Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility
verfasst von
Daniel Sevlever
Fanggeng Zou
Li Ma
Sebastian Carrasquillo
Michael G. Crump
Oliver J. Culley
Talisha A. Hunter
Gina D. Bisceglio
Linda Younkin
Mariet Allen
Minerva M. Carrasquillo
Sigrid B. Sando
Jan O. Aasly
Dennis W. Dickson
Neill R. Graff-Radford
Ronald C. Petersen
Ferenc Deák
Olivia Belbin
Kevin Morgan for ARUK consortium
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Molecular Neurodegeneration / Ausgabe 1/2015
Elektronische ISSN: 1750-1326
DOI
https://doi.org/10.1186/s13024-015-0047-2

Weitere Artikel der Ausgabe 1/2015

Molecular Neurodegeneration 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.